Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States

View source ↗

Summary

An observational study update evaluating how Elinzanetant is used and how effective it is for women with menopause-related vasomotor symptoms in the United Stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elinzanetant (elinzanetant)

Snippet

Sponsor: Bayer | Conditions: Vasomotor Symptoms (VMS) Associated With Menopause | Status: NOT_YET_RECRUITING